45
In band
Moving averages
SMA 200$9.04+11.50%
Company profile
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
SectorHealthcare
IndustryBiotechnology
Market cap$2.09B
P/E ratioNone
EPS$-1.58
Beta2.435
Dividend yield0.00%
52-week high$13.39
52-week low$6.20
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
AUPH
Aurinia Pharmaceuticals Inc
RSI 49
SRPT
Sarepta Therapeutics Inc
RSI 51
NTLA
Intellia Therapeutics Inc
RSI 53
GPCR
Structure Therapeutics Inc
RSI 27
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 54
RSI alerts for NVAX
An email when NVAX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:09 PM EDT